SEC 13F Intelligence

Octagon Capital Advisors LP / NVLSEUR

Octagon Capital Advisors LP’s Alpine Immune Sciences Inc Position

Does Octagon Capital Advisors LP own Alpine Immune Sciences Inc (NVLSEUR)? Not currently — the last reported position was 1.24M shares worth $49M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$49M
Q1 2024
Shares
1.24M
% of Portfolio
+5.90%
Quarters Held
7
position exited

Position History NVLSEUR

Reported value by quarter
Q3 ’22: $9MQ3 ’22Q4 ’22: $9MQ4 ’22Q1 ’23: $9MQ1 ’23Q2 ’23: $8MQ2 ’23Q3 ’23: $9MQ3 ’23Q4 ’23: $24MQ4 ’23Q1 ’24: $49MQ1 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20241.24M$49M+5.90%
Q4 20231.24M$24M+3.79%
Q3 2023750.0K$9M+1.32%
Q2 2023750.0K$8M+1.07%
Q1 20231.20M$9M+1.34%
Q4 20221.23M$9M+1.40%
Q3 20221.23M$9M+1.52%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Octagon Capital Advisors LP’s full portfolio or all institutional holders of NVLSEUR.